Editorial: Case reports in cardio-oncology: 2022.
作者信息
Ewer Michael S, Yusuf Syed Wamique, Asmis Reto, Abe Jun-Ichi
机构信息
MD Anderson Department of Cardiology, Internal Medicine Division, The University of Texas, Houston, TX, United States.
Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.
出版信息
Front Cardiovasc Med. 2023 Jul 13;10:1235015. doi: 10.3389/fcvm.2023.1235015. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Case reports in cardio-oncology: 2022.社论：心血管肿瘤学病例报告：2022年
Front Cardiovasc Med. 2023 Jul 13;10:1235015. doi: 10.3389/fcvm.2023.1235015. eCollection 2023.
2
The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patients.澳大利亚和新西兰心血管肿瘤登记处：全国儿科癌症患者队列中化疗相关心脏毒性的评估。
Intern Med J. 2021 Feb;51(2):229-234. doi: 10.1111/imj.14719.
3
Inequity in care delivery in cardio-oncology: dissecting disparities in underrepresented populations.心脏肿瘤学护理提供中的不公平现象：剖析弱势群体中的差异。
Front Oncol. 2023 Jun 9;13:1124447. doi: 10.3389/fonc.2023.1124447. eCollection 2023.
4
Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic.设立心脏肿瘤学科室的基本原理：我们在梅奥诊所的经验。
Cardiooncology. 2016 Apr 19;2(1):5. doi: 10.1186/s40959-016-0014-2.
5
Editorial: Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-Oncology: From Bench to Bedside.社论：心脏肿瘤学中心血管和代谢功能障碍的新挑战：从实验室到临床
Front Cardiovasc Med. 2020 Aug 26;7:148. doi: 10.3389/fcvm.2020.00148. eCollection 2020.
6
Future steps in cardio-oncology-a national multidisciplinary survey among healthcare professionals in the Netherlands.未来的心血管肿瘤学步骤——荷兰医疗保健专业人员的全国多学科调查。
J Cancer Surviv. 2023 Aug;17(4):1131-1138. doi: 10.1007/s11764-022-01163-6. Epub 2022 Feb 4.
7
The EACVI survey on cardiac imaging in cardio-oncology.欧洲心血管影像学会心血管肿瘤学心脏影像学调查
Eur Heart J Cardiovasc Imaging. 2021 Mar 22;22(4):367-371. doi: 10.1093/ehjci/jeaa111.
8
What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist?心血管肿瘤学服务为肿瘤学家和血液学家提供了什么？
Clin Oncol (R Coll Radiol). 2021 Aug;33(8):483-493. doi: 10.1016/j.clon.2021.03.012. Epub 2021 Apr 5.
9
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.血清生物标志物在接受心脏毒性癌症治疗的癌症患者中的作用：心力衰竭协会的心脏肿瘤学研究小组和欧洲心脏病学会的心脏肿瘤学理事会的立场声明。
Eur J Heart Fail. 2020 Nov;22(11):1966-1983. doi: 10.1002/ejhf.2017. Epub 2020 Oct 20.
10
Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo.巴西心血管肿瘤学：圣保罗州立癌症研究所的 10 年经验。
BMC Cardiovasc Disord. 2020 Apr 28;20(1):206. doi: 10.1186/s12872-020-01471-8.
引用本文的文献
1
Nursing knowledge in cardio-oncology: results of an international learning needs-assessment survey.心脏肿瘤学中的护理知识：一项国际学习需求评估调查的结果
Cardiooncology. 2025 Jan 16;11(1):4. doi: 10.1186/s40959-025-00304-x.
本文引用的文献
1
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).2022年欧洲心脏病学会（ESC）与欧洲血液学协会（EHA）、欧洲治疗放射学与肿瘤学协会（ESTRO）以及国际心脏肿瘤学会（IC-OS）合作制定的心脏肿瘤学指南。
Eur Heart J. 2022 Nov 1;43(41):4229-4361. doi: 10.1093/eurheartj/ehac244.
2
Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment.免疫检查点抑制剂相关性心肌炎：病理生理特征、诊断与治疗
J Am Heart Assoc. 2020 Jan 21;9(2):e013757. doi: 10.1161/JAHA.119.013757.
3
False Positive Cardiotoxicity Events in Cancer-Related Clinical Trials: Risks Related to Imperfect Noninvasive Parameters.癌症相关临床试验中的假阳性心脏毒性事件：与非侵入性参数不完善相关的风险。
Chemotherapy. 2018;63(6):324-329. doi: 10.1159/000495147. Epub 2019 Mar 7.
4
Radiation-Induced Cardiovascular Disease.辐射诱发的心血管疾病
Curr Atheroscler Rep. 2017 May;19(5):22. doi: 10.1007/s11883-017-0658-x.
5
Cardiac Monitoring During Adjuvant Trastuzumab-Based Chemotherapy Among Older Patients With Breast Cancer.老年乳腺癌患者辅助性曲妥珠单抗化疗期间的心脏监测
J Clin Oncol. 2015 Jul 1;33(19):2176-83. doi: 10.1200/JCO.2014.58.9465. Epub 2015 May 11.
6
Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.早期发现蒽环类药物心脏毒性并通过心力衰竭治疗得到改善。
Circulation. 2015 Jun 2;131(22):1981-8. doi: 10.1161/CIRCULATIONAHA.114.013777. Epub 2015 May 6.
7
A historical perspective of anthracycline cardiotoxicity.蒽环类药物心脏毒性的历史观点。
Heart Fail Clin. 2011 Jul;7(3):363-72. doi: 10.1016/j.hfc.2011.03.001. Epub 2011 May 14.
8
MDGs: chronic diseases are not on the agenda.千年发展目标：慢性病未被列入议程。
Lancet. 2005;366(9496):1512-4. doi: 10.1016/S0140-6736(05)67610-6.
9
Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity.II型化疗相关心脏功能障碍：是时候认识一种新的疾病实体了。
J Clin Oncol. 2005 May 1;23(13):2900-2. doi: 10.1200/JCO.2005.05.827.
10
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.对于过度表达HER2的转移性乳腺癌，使用化疗加一种抗HER2单克隆抗体进行治疗。
N Engl J Med. 2001 Mar 15;344(11):783-92. doi: 10.1056/NEJM200103153441101.
Zotero 插件